Musasia, Fauzia K.
Nkumama, Irene N.
Frank, Roland
Kipkemboi, Victor
Schneider, Martin
Mwai, Kennedy http://orcid.org/0000-0002-7757-7516
Odera, Dennis O.
Rosenkranz, Micha
Fürle, Kristin
Kimani, Domitila
Tuju, James
Njuguna, Patricia
Hamaluba, Mainga http://orcid.org/0000-0002-0266-1414
Kapulu, Melissa C.
Wardemann, Hedda http://orcid.org/0000-0003-3921-5933
Abdi, Abdirahman I.
Abebe, Yonas
Bejon, Philip
Billingsley, Peter F.
Bull, Peter C.
de Laurent, Zaydah
Hoffman, Stephen L.
James, Eric R.
Kariuki, Silvia
Kimathi, Rinter
Kinyanjui, Sam
Kivisi, Cheryl
Makale, Johnstone
Marsh, Kevin
Mohammed, Khadija Said
Mosobo, Moses
Musembi, Janet
Musyoki, Jennifer
Muthui, Michelle
Mwacharo, Jedidah
Ndungu, Francis
Ngoi, Joyce M.
Ngoto, Omar
Ogutu, Bernhards
Olewe, Fredrick
Omuoyo, Donwilliams
Ong’echa, John
Otieno, Edward
Shangala, Jimmy
Sim, Betty Kim Lee
Richie, Thomas L.
Wambua, Juliana
Williams, Thomas N.
Osier, Faith H. A. http://orcid.org/0000-0001-7133-5375
,
Article History
Received: 8 February 2021
Accepted: 27 June 2022
First Online: 14 July 2022
Competing interests
: B.K.L.S., Y.A., P.F.B., S.L.H, E.R.J., TR. are salaried, full-time employees of Sanaria Inc., the manufacturer of Sanaria PfSPZ Challenge. Thus, all authors associated with Sanaria Inc. have potential conflicts of interest. All other authors declare no competing interests.
: Ethical approval for the Junju study was provided by the Kenyan National and Scientific Ethics Review Committee protocol number KEMRI/SERU/CGMR-C/022/3149. The CHMI study was conducted at the KEMRI Wellcome Trust Research Programme in Kilifi, Kenya with ethical approval from the KEMRI Scientific and Ethics Review Unit (KEMRI//SERU/CGMR-C/029/3190) and the University of Oxford Tropical Research Ethics Committee (OxTREC 2–16). All participants gave written informed consent. The study was registered on ClinicalTrials.gov (NCT02739763), conducted based on good clinical practice (GCP), and under the principles of the Declaration of Helsinki.